Skip to main content
. 2017 Feb 28;12(1):22. doi: 10.1007/s11657-017-0316-5

Fig. 2.

Fig. 2

Rates of persistence and compliance with osteoporosis therapies during 12- and 24-month follow-up. Rates of persistence (white bars) and compliance (black bars) among women receiving osteoporosis therapies of interest during a 12-month and b 24-month follow-up. IV intravenous, QD once daily, QM once monthly, Q3M once every 3 months, Q6M once every 6 months, QW once a week, SC subcutaneous